Cargando…

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016

It is well-documented that early HIV diagnosis and linkage to care reduces morbidity and mortality as well as HIV transmission. We estimated the median time from HIV infection to diagnosis in the European Union/European Economic Area (EU/EEA) at 2.9 years in 2016, with regional variation. Despite ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Sighem, Ard, Pharris, Anastasia, Quinten, Chantal, Noori, Teymur, Amato-Gauci, Andrew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2017
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725787/ https://www.ncbi.nlm.nih.gov/pubmed/29208159 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.48.17-00771

Ejemplares similares

Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015
por: Pharris, Anastasia, et al.
Publicado: (2016)

Authors' reply: New metrics to monitor progress towards global HIV targets: using the estimated number of undiagnosed HIV-infected individuals as denominator
por: Pharris, Anastasia, et al.
Publicado: (2016)

Potential adjustment methodology for missing data and reporting delay in the HIV Surveillance System, European Union/European Economic Area, 2015
por: Rosinska, Magdalena, et al.
Publicado: (2018)

HIV among women in the WHO European Region – epidemiological trends and predictors of late diagnosis, 2009-2018
por: Mårdh, Otilia, et al.
Publicado: (2019)

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
por: Cristea, Veronica, et al.
Publicado: (2023)

Assessment of HIV molecular surveillance capacity in the European Union, 2016
por: Keating, Patrick, et al.
Publicado: (2017)

HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets
por: Brown, Alison E, et al.
Publicado: (2018)

Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022
por: Linkevicius, Marius, et al.
Publicado: (2023)

The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area
por: Cole, Michelle J., et al.
Publicado: (2019)

Tuberculosis among migrant populations in the European Union and the European Economic Area
por: Odone, Anna, et al.
Publicado: (2015)

Substantial Heterogeneity in Progress Toward Reaching the 90-90-90 HIV Target in the WHO European Region
por: Porter, Kholoud, et al.
Publicado: (2018)

Measles among migrants in the European Union and the European Economic Area
por: Williams, Gemma A., et al.
Publicado: (2015)

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
por: Merk, Hanna, et al.
Publicado: (2019)

Health crisis in Venezuela: Status of communicable diseases and implications for the European Union and European Economic Area, May 2019
por: Espinosa, Laura, et al.
Publicado: (2019)

Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020
por: Johnson, Helen C, et al.
Publicado: (2020)

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
por: Kohlenberg, Anke, et al.
Publicado: (2018)

Piloting a surveillance system for HIV drug resistance in the European Union
por: van de Laar, Marita JW, et al.
Publicado: (2019)

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020)

Is tuberculosis crossing borders at the Eastern boundary of the European Union?
por: van der Werf, Marieke J., et al.
Publicado: (2013)

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?
por: Vourli, Georgia, et al.
Publicado: (2020)

Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018
por: Peñalva, Germán, et al.
Publicado: (2019)

Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
por: Kinross, Pete, et al.
Publicado: (2020)

Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014
por: Miglietta, Alessandro, et al.
Publicado: (2018)

People living with undiagnosed HIV infection and a low CD4 count: estimates from surveillance data, Italy, 2012 to 2014
por: Regine, Vincenza, et al.
Publicado: (2018)

Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019
por: Hayes, Rosalie, et al.
Publicado: (2019)

Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012
por: Walter, Jan, et al.
Publicado: (2018)

Towards standardized definitions for monitoring the continuum of HIV care in Europe
por: Gourlay, Annabelle J., et al.
Publicado: (2017)

Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

COVID-19 trends and severity among symptomatic children aged 0–17 years in 10 European Union countries, 3 August 2020 to 3 October 2021
por: Bundle, Nick, et al.
Publicado: (2021)

The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges
por: Gourlay, Annabelle, et al.
Publicado: (2017)

HIV diagnoses among people born in Ukraine reported by EU/EEA countries in 2022: impact on regional HIV trends and implications for healthcare planning
por: Reyes-Urueña, Juliana, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020
por: Simões, Daniel, et al.
Publicado: (2020)

High monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in Europe, 30 July to 12 August 2022
por: Reyes-Urueña, Juliana, et al.
Publicado: (2022)

Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016
por: Harvala, Heli, et al.
Publicado: (2017)

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review
por: Desai, S, et al.
Publicado: (2019)

HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance
por: Croxford, S, et al.
Publicado: (2019)

Economic citizenship in the European Union : employment relations in the new Europe
por: Teague, Paul
Publicado: (1999)

Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data
por: van Sighem, Ard, et al.
Publicado: (2015)

The 2016 European Union report on pesticide residues in food
Publicado: (2018)

Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area
por: van den Wijngaard, Cees C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hi9tukjcikm03a6t4q9nqaae36